GlassScriptPhysician profile
Dzanan Ramic
NPI 1093975914
$3,720.08
in general payments reported to CMS, 2019-2025
12 companies · $210 in 2025
The $210 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,699 · 2020: $198 · 2021: $286 · 2022: $305 · 2023: $690 · 2024: $332 · 2025: $210.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,232.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,232.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,385.15 | 2019 | |
| Abiomed | $1,020.16 | 2019-2025 | Impella |
| Boston Scientific Corporation | $511.53 | 2019-2025 | Avvigo Guidance System |
| Medtronic, INC. | $396.01 | 2021-2024 | Linq II, Corevalve Evolut R, Cobalt Dr Mri Surescan |
| Abbott Laboratories | $142.02 | 2019-2023 | Portico |
| Shockwave Medical, INC | $128.22 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| E.R. Squibb & Sons, L.L.C. | $34.10 | 2023 | Eliquis, Camzyos |
| Janssen Pharmaceuticals, INC | $28.29 | 2021 | |
| Inari Medical, INC. | $20.38 | 2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $20.25 | 2020 | |
| Pfizer INC. | $17.14 | 2023 | |
| Cardiva Medical, INC. | $16.83 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dzanan Ramic listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.